Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 1
1975 1
1977 1
1978 1
1983 2
1985 1
1987 2
1988 1
1990 1
1991 3
1992 2
1993 1
1999 2
2000 1
2001 3
2002 5
2003 2
2004 2
2006 1
2007 3
2008 4
2009 2
2010 1
2011 2
2012 1
2014 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Screening and prostate-cancer mortality in a randomized European study.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18. N Engl J Med. 2009. PMID: 19297566 Free article. Clinical Trial.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators. Schröder FH, et al. Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6. Lancet. 2014. PMID: 25108889 Free PMC article. Clinical Trial.
[Erectile impotence].
Juusela H, Hovatta O. Juusela H, et al. Duodecim. 1983;99(3):194-201. Duodecim. 1983. PMID: 6347639 Review. Finnish. No abstract available.
[Treatment of urolithiasis].
Juusela H, Ala-Opas M. Juusela H, et al. Duodecim. 1983;99(20):1478-82. Duodecim. 1983. PMID: 6360646 Review. Finnish. No abstract available.
Prostate-cancer mortality at 11 years of follow-up.
Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Páez A, Määttänen L, Bangma CH, Aus G, Carlsson S, Villers A, Rebillard X, van der Kwast T, Kujala PM, Blijenberg BG, Stenman UH, Huber A, Taari K, Hakama M, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators. Schröder FH, et al. N Engl J Med. 2012 Mar 15;366(11):981-90. doi: 10.1056/NEJMoa1113135. N Engl J Med. 2012. PMID: 22417251 Free PMC article. Clinical Trial.
Three-year results of the Finnish prostate cancer screening trial.
Määttänen L, Auvinen A, Stenman UH, Tammela T, Rannikko S, Aro J, Juusela H, Hakama M. Määttänen L, et al. Among authors: juusela h. J Natl Cancer Inst. 2001 Apr 4;93(7):552-3. doi: 10.1093/jnci/93.7.552. J Natl Cancer Inst. 2001. PMID: 11287450 No abstract available.
Lead-time in prostate cancer screening (Finland).
Auvinen A, Määttänen L, Stenman UH, Tammela T, Rannikko S, Aro J, Juusela H, Hakama M. Auvinen A, et al. Among authors: juusela h. Cancer Causes Control. 2002 Apr;13(3):279-85. doi: 10.1023/a:1015040231402. Cancer Causes Control. 2002. PMID: 12020110
48 results